Vigil Neuroscience (VIGL) Market Capitalization

The daily price chart for Vigil Neuroscience (VIGL) on the GURU.Markets platform recorded a value of 0.39. Price action is subject to the influence of clinical trial uncertainty and a dependence on external R&D investments. The business relies on creating a proprietary therapy network via microglia modulation and TREM2 agonists. Simultaneously, Vigil Neuroscience (VIGL) is implementing energy-saving technologies and emission filtration in its laboratories in accordance with ESG standards.

VIGL Vigil Neuroscience Inc.: Market Value in the range 07/04/2022 - 08/16/2025

VIGL (vigilneuro.com): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price Vigil Neuroscience, Inc.|VIGL - Analyst Median Target

- market capitalization details:

Market Capitalization Vigil Neuroscience, Inc.|VIGL - Full Takeover Company Value

- issuer book value statistics:

Net Assets per Single Share Vigil Neuroscience|VIGL - Company Book Value|Market Value to Book Value Ratio vigilneuro.com|VIGL - Total Business Assets

- debt and liquidity details:

Total Debt to Capital Vigil Neuroscience|VIGL - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Vigil Neuroscience, Inc.|VIGL - Company Aggregate Debts|Debt to Book Capitalization Ratio Vigil Neuroscience, Inc.|VIGL - Company Long-Term Loans and Borrowings|Company Short-Term Debt Vigil Neuroscience|Quick Liquidity Indicator vigilneuro.com

- business earnings and investment ratios data:

VIGL - Company Net Income|Projected Future Earnings Vigil Neuroscience|VIGL - Business Payback Period|Forward P/E Multiple Vigil Neuroscience, Inc.|VIGL - Price to Net Income Growth Ratio|EV/EBITDA Multiple Vigil Neuroscience, Inc.|VIGL - Operating income before deduction of amortization|Earnings per share for the last twelve months Vigil Neuroscience|VIGL - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months vigilneuro.com|VIGL - Earnings per share increase in current year|Net earnings per share growth forecast for next year Vigil Neuroscience

Fundamental company analysis:VIGL (Vigil Neuro)

Product sample of Vigil Neuroscience Inc.

Vigil Neuroscience (VIGL) is developing a high-tech portfolio of neurotherapeutic agents, utilizing external manufacturing capacities to minimize capital expenditures. The total market capitalization trend reflects the market value of all shares, combining current demand and expectations for clinical success. This indicator measures the aggregate capital that investors are willing to allocate to the virtual business model. An increase in this metric signals a recovery of confidence in the assets following volatility. Timely trend analysis allows for the identification of an entry point prior to a valuation rerating.

Key competitors